Madison Capital To Suspend Trading Due To Failure To Complete A QT Within 24 Months Of Listing
Dec 3 13
Further to the TSX Venture Exchange Bulletin dated November 4, 2013, effective at the open, December 4, 2013, trading in the shares of Madison Capital Corporation will be suspended, the Company having failed to complete a Qualifying Transaction (QT) within 24 months of its listing. Members are prohibited from trading in the securities of the Company during the period of the suspension or until further notice.
Madison Capital Corporation and Radient Technologies Inc. Announce Management Appointments to Newco
Nov 21 13
Madison Capital Corporation has entered into a letter agreement with Radient Technologies Inc., dated November 18, 2013, pursuant to which Madison will amalgamate, or complete a plan of arrangement, with Radient to form Newco. The parties acknowledge that at the shareholders meeting of Madison to approve the Transaction, the board of directors of Newco will be approved to consist of 10, being Denis Taschuk, Armand Lavoie, Mike Cabigon, Ian Newton, Chris Lumb, Hans Black, Wolfgang Muhs, Harry Kaura, Prakash Hariharan and Steven Dauphin, provided the TSX Venture does not object to such nominations and such persons are eligible to act as directors pursuant to the requirements of applicable corporate law. After the closing of the transaction, the officers of Newco will be appointed by the Board of Directors of Newco and will include Denis Taschuk as President and Chief Executive Officer, Steven Splinter as Chief Technology Officer, Randy Fries as Chief Financial Officer, Stéphane Gagné as Director, Strategic Partnerships and a Corporate Secretary to be determined by the Board of Directors of Newco. Mr. Taschuk has over twenty-five years of business experience, including corporate strategy development, manufacturing, market development and finance. Prior to joining Radient in October 2011, Mr. Taschuk was a partner and the CEO of JAG Flocomponents LP from September 2004 to May 2010. Dr. Splinter is a founder and was the first President of Radient, commencing July 2002. He is experienced in strategic planning, technical assessment and development of process technologies, business leadership, and engineering project management. Prior to founding Radient, Dr. Splinter served as Director of Chemical & Environmental Processes at BC Research Inc., where he built and managed a team of scientists, engineers and technologists providing contract research and development services to various clients in the area of chemical process development. Mr. Fries has over twenty years of business experience, primarily working with companies and business owners in times of crisis or transition. Since September 2005, he has provided mergers & acquisition, restructuring and interim CFO consulting services through Fries Financial Consulting Ltd. to a number of private and public companies. Mr. Fries was the Chief Financial Officer of PetroCorp Group Inc. from December 2009 to August 2013. Mr. Gagné has over twenty years of experience in the fields of cosmetics, nutritional supplements, pharmaceutical products and active ingredients. He previously held the position of VP Sales and Marketing (Asia) and Director Sales and Marketing (Nutrition) for Atrium Biotechnologies Inc. and was the Director Sales and Marketing for Aeterna-Zentaris Inc. Since January 2000, Mr. Lavoie has been the Managing Director of Foragen Technologies Management Inc., the general partner of Foragen. Since August 2008, Mr. Cabigon has been the President and Managing Partner of Foundation Equity Corporation, where he develops the short and long-term investment initiatives of each of its funds, and actively works with portfolio companies on strategy, marketing, financing, and operations. He is currently Chairman of Rocketfuel DSC, a Director of DriveABLE Assessment Centres, and a board observer at McCoy Corporation since September 2008. Mr. Newton is the principal of Ceres Consulting Inc. and an internationally recognized expert in human nutrition. Since December 2009, Mr. Lumb has been the CEO of TEC Edmonton, a joint venture between the University of Alberta and Edmonton Economic Development Corporation. Prior to joining TEC Edmonton, and since 1994 Mr. Lumb was the President and CEO of Micralyne Inc., where he was involved in all aspects of the company's development, including leading its transition from a university-owned not-for-profit to a privately held commercial company generating long-term revenue growth and delivering profitable net income and return on equity. Dr. Hans Peter Black is Chairman of the Board and Chief Investment Strategist of Interinvest Corp. Dr. Black is Chairman of the Board of Wi2Wi Inc. He has been a Non Independent Director at Williams Creek Gold Limited since December 2011. Dr. Muhs is an experienced executive from the fine chemical industry. He was VP Custom Manufacturing & Intermediates for Rhodia Pharma Solutions in England, and since November 2003 has been a Director (Chairman of the Board from May 2006 to December 2012) of Innovotech Inc. Mr. Kaura has over twenty years experience in various fields such as engineering, real estate, construction and operations. Since 2002, Mr. Kaura's interests have expanded to include real estate acquisition and construction, which are conducted by Amnor Group Inc. Mr. Hariharan was a portfolio manager for Front Street Capital, which he joined in 2005. Mr. Dauphin co-founded Bonaventure Capital in April 1998 and Fidelis Capital in 2001, and he leads certain private market activities for both firms. From 1994 to 1998, Mr. Dauphin worked with the Harbinger Group as both a Director and a Managing Director.